Single Source: Human Tumor Atlas Network Data Coordinating Center (HTAN-DCC; U24 Clinical Trial Not Allowed)
Funding Opportunity RFA-CA-23-041 from the NIH Guide for Grants and Contracts. Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to accelerate sharing of complex single-cell level data with the cancer research community. The Human Tumor Atlas Network Data Coordinating Center (HTAN-DCC) will serve the dual role of network and data coordination. Administratively the HTAN-DCC will be responsible for meeting coordination, including planning and administration of monthly HTAN Steering Committee meetings, monthly HTAN working group meetings, and semi-annual HTAN face-to-face meetin...
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 3, 2023 Category: Research Source Type: funding
Single Budget Line Item Requirement for Data Management and Sharing Costs Rescinded
Currently, grant applicants submitting detailed budgets must request costs to support Data Management and Sharing (DMS) Plan activities as a single line item on the R&R Budget Form titled “Data Management and Sharing Costs.” This requirement will be rescinded for due dates on or after October 5, 2023 (NOT-OD-23-161).
For applications with due dates on or after October 5, 2023, DMS costs must be included with other costs in the appropriate cost categories (e.g., personnel, equipment, supplies, other expenses), following standard form instructions. For example, personnel costs associated with data management and s...
Source: NIH Extramural Nexus - August 15, 2023 Category: Research Authors: NIH Staff Tags: Top Stories Data sharing Grants policy Source Type: funding
Notice of Change to Budget Instructions in PAR-23-145 "Maximizing Investigators Research Award (MIRA) for Early Stage Investigators (ESI) (R35 - Clinical Trial Optional)"
Notice NOT-GM-23-049 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 15, 2023 Category: Research Source Type: funding
Notice of Change to Award Budget for RFA-NS-21-029, "HEAL Initiative: Planning Studies for Initial Analgesic Development [Small Molecules and Biologics] (R61 Clinical Trial Not Allowed)
Notice NOT-NS-23-105 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 9, 2023 Category: Research Source Type: funding
Notice of Correction to Award Budget in RFA-RM-23-013 "Partnerships with Common Fund Data Ecosystem Resources (U24 Clinical Trial not Allowed)"
Notice NOT-RM-23-022 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 24, 2023 Category: Research Source Type: funding
Notice of Correction to Budget Form and Budget Instructions for RFA-RM-23-004 "NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)"
Notice NOT-RM-23-021 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 24, 2023 Category: Research Source Type: funding
Final Career Stage Analyses of Applications Submitted During the Pandemic (Part 7)
The HHS-declared public health emergency for COVID-19 ended on May 11, 2023 (NOT-OD-23-095). With this milestone, we are also closing out our series of blogs on the distributions of gender and race of designated principal investigators (PIs) of R01 and RPG applications submitted before and after the onset of the pandemic. This final post builds on previous career stage analyses, specifically focusing on applications received between September 8 and May 7 over several consecutive years.
Our first four analyses (from April 2022, October 2021, June 2021, and July 2020) did not show any marked changes in...
Source: NIH Extramural Nexus - July 10, 2023 Category: Research Authors: Mike Lauer Tags: blog Open Mike applications career stage COVID-19 Funding data Source Type: funding
Notice of Correction to Award Budget in RFA-CA-23-027 "Advancing Cancer Control Equity Research through Transformative Solutions Coordination Center (U24 Clinical Trial Optional)"
Notice NOT-CA-23-077 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 10, 2023 Category: Research Source Type: funding
Notice of Correction to modify the label to R and R Budget" for RFA-RM-23-005 "NIH Directors New Innovator Award Program (DP2 Clinical Trial Optional)"
Notice NOT-RM-23-020 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 7, 2023 Category: Research Source Type: funding
More Early Stage Investigators Supported in FY 2022
Discussion and Funding Rates for PIs on Type 1 R01-Equivalent Applications and Awards in FY 2022 by Career Stage
Career StageApplicantsDiscussedAwardeesDiscussion Rate (%)*Funding Rate (%)Early Stage54353466160963.829.6New, Not Early72413750125751.817.4At Risk77364570208759.127.0Established110457847359871.032.6
* The Discussion Rate is a person-based metric that is the percent of applicants (actually people designated as PI’s on an application) who had at least one application make it to the discussion stage of peer review.
The next set of tables present aggregate data for sex/gender (Table 3), race (Table 4), e...
Source: NIH Extramural Nexus - June 5, 2023 Category: Research Authors: Mike Lauer Tags: blog Open Mike ESI Funding data NGRI Source Type: funding
Collaborative Opportunities for Multidisciplinary, Bold, and Innovative Neuroscience (COMBINE) (RM1 Clinical Trial Optional)
Funding Opportunity RFA-NS-23-027 from the NIH Guide for Grants and Contracts. Reissue of RFA-NS-22-011 to comply with DMSP changes. No changes to receipt dates or locus of review. This funding opportunity announcement (FOA) is designed to support integrated efforts of three or more (up to six) PDs/PIs to pursue bold, impactful, and challenging research in any area within the scope of the NINDS mission. The research approach should be interdisciplinary in nature, and the research teams are expected to establish a common goal that requires collaboration, synergy, and managed team interactions. Proposed research should no...
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 15, 2023 Category: Research Source Type: funding
Check Out These Public Federal Funding Databases to Learn More About Funding at NIH and Other Federal Agencies
We often recommend NIH RePORT (Research Portfolio Online Reporting Tools) site to applicants & awardees because it publicly provides reports, data, and analyses of NIH research activities, including information on NIH expenditures and the results of NIH-supported research. The RePORT suite includes:
NIH RePORTER (RePORT Expenditures and Results) allows users to search for funded projects, investigators, publications, and patents (see this NIH Open Mike blog for more). REPORTER also includes information on research projects funded by the Centers for Disease Control and Prevention, Food and Drug Administration, Agenc...
Source: NIH Extramural Nexus - May 9, 2023 Category: Research Authors: NIH Staff Tags: Tips Before You Submit Funding data Source Type: funding
Update on Improving Fellowship Review: A Request for Information
This blog has been co-authored with Noni Byrnes, Director, Center for Scientific Review, NIH. Originally posted on the Review Matters blog.
Mike Lauer, Deputy Director for Extramural Research, NIH
Noni Byrnes, Ph.D., Director of NIH Center for Scientific Review
NIH is recommending changes to the peer review of Ruth L. Kirschstein National Research Service Award (NRSA) fellowship applications by restructuring the review criteria and modifying some sections of the PHS Fellowship Supplemental Form that are specific to NRSAs. The goal of this effort is to facilitate the mission of NRSA fellowship peer review – to iden...
Source: NIH Extramural Nexus - April 25, 2023 Category: Research Authors: Mike Lauer Tags: blog Open Mike fellowship NRSA request for information Request For Information (RFI) Review Source Type: funding
Lasker Clinical Research Scholars Program (Si2/R00 Clinical Trial Optional)
Funding Opportunity PAR-23-156 from the NIH Guide for Grants and Contracts. This FOA encourages applications for the Lasker Clinical Research Scholars Program for the purpose of supporting the research activities during the early stage careers of independent clinical researchers. The program offers the opportunity for a unique bridge between the NIH intramural and extramural research communities and contains two phases. In the first phase, Lasker Scholars will receive appointments for up to 5-7 years as tenure-track investigators within the NIH Intramural Research Program with independent research budgets. In the second...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 17, 2023 Category: Research Source Type: funding
Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)
Funding Opportunity PAR-23-157 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) uses a R61/R33 Phased Innovation Award mechanism to support clinical research applications that are exploratory and developmental in nature and focus on understanding the neurobiological mechanisms underlying SUD, including fundamental brain function relevant to substance use. This FOA is particularly designed to support exploratory/developmental projects requiring budgets that would exceed that allowed for the R21 mechanism (Neuroscience Research on Drug Abuse (R21 Clinical Trial Optional) (Source: NI...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 10, 2023 Category: Research Source Type: funding
